| |
| |
|
| Insider
Information: |
Bozigian Haig P. |
| Relationship: |
Chief Development Offi... |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
157,651 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$21,550,892 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
157,651 |
|
|
| Total
Value |
$21,550,892 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Neurocrine Biosciences Inc |
NBIX |
Chief Development Offi... |
2021-02-08 |
157,651 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
92 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NBIX |
Neurocrine Biosciences In... |
Sr Vice President, Development |
• – – |
2008-01-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
247 |
|
- |
|
| NBIX |
Neurocrine Biosciences In... |
Sr Vice President, Development |
• – – |
2008-02-05 |
4 |
AS |
$5.31 |
$3,831 |
D/D |
(722) |
1,191 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Sr Vice President, Development |
• – – |
2008-09-29 |
4 |
AS |
$4.70 |
$16,987 |
D/D |
(3,618) |
6,382 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Sr Vice President, Development |
• – – |
2009-01-05 |
4 |
AS |
$3.40 |
$2,489 |
D/D |
(733) |
8,614 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Sr Vice President, Development |
• – – |
2009-03-30 |
4 |
AS |
$3.43 |
$43,780 |
D/D |
(12,774) |
29,423 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Sr Vice President, Development |
• – – |
2009-09-28 |
4 |
AS |
$3.11 |
$11,337 |
D/D |
(3,642) |
35,781 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Sr Vice President, Development |
• – – |
2010-01-04 |
4 |
AS |
$2.64 |
$1,983 |
D/D |
(751) |
36,697 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Sr Vice President, Development |
• – – |
2010-03-01 |
4 |
AS |
$2.53 |
$35,589 |
D/D |
(14,090) |
55,940 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Sr Vice President, Development |
• – – |
2011-02-28 |
4 |
AS |
$6.83 |
$84,085 |
D/D |
(12,320) |
76,954 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2013-06-20 |
4 |
AS |
$12.30 |
$255,651 |
D/D |
(20,769) |
76,954 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2013-06-21 |
4 |
AS |
$12.50 |
$303,375 |
D/D |
(23,962) |
76,954 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2013-06-24 |
4 |
AS |
$12.72 |
$9,782 |
D/D |
(769) |
76,954 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2013-06-27 |
4 |
AS |
$13.00 |
$104,000 |
D/D |
(8,000) |
76,954 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2013-08-05 |
4 |
AS |
$15.00 |
$165,015 |
D/D |
(11,001) |
76,954 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2013-08-21 |
4 |
AS |
$15.01 |
$210,552 |
D/D |
(13,999) |
76,954 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2014-01-07 |
4 |
AS |
$17.50 |
$437,500 |
D/D |
(25,000) |
76,954 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2014-01-10 |
4 |
AS |
$18.58 |
$30,193 |
D/D |
(1,625) |
78,579 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
CHIEF DEVELOPMENT OFFICER |
• – – |
2014-01-17 |
4 |
AS |
$20.00 |
$500,000 |
D/D |
(25,000) |
78,579 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
CHIEF DEVELOPMENT OFFICER |
• – – |
2014-01-17 |
4 |
OE |
$2.59 |
$77,400 |
D/D |
25,000 |
103,579 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2014-12-12 |
4 |
OE |
$2.59 |
$38,545 |
D/D |
9,998 |
88,577 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2014-12-12 |
4 |
AS |
$22.50 |
$224,955 |
D/D |
(9,998) |
78,579 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2014-12-15 |
4 |
OE |
$5.12 |
$12,800 |
D/D |
2,500 |
81,079 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2014-12-15 |
4 |
AS |
$21.72 |
$54,300 |
D/D |
(2,500) |
78,579 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2014-12-17 |
4 |
AS |
$22.51 |
$337,695 |
D/D |
(15,002) |
78,579 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2014-12-17 |
4 |
OE |
$2.59 |
$38,855 |
D/D |
15,002 |
93,581 |
0 |
- |
|
92 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
